Theseus Investor Seeks Appraisal After Concentra Merger
By Leslie A. Pappas · April 2, 2024, 8:28 PM EDT
A fund invested in clinical-stage biopharmaceutical company Theseus Pharmaceuticals Inc. has petitioned Delaware's Court of Chancery for an appraisal of the investor's 250,000 shares following Theseus' $4.05 per-share consolidation in February with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login